Pharvaris

-$0.47 (-3.00%) Today
-$0.06 (-0.39%) As of 10:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharvaris and other ETFs, options, and stocks.

About PHVS

Pharvaris NV is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases.

CEO
Berndt A. E. Modig
Employees
—
Headquarters
Leiden, Zuid-Holland
Founded
2015

PHVS Key Statistics

Market Cap
504.24M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
5.54K
High Today
$16.12
Low Today
$15.01
Open Price
$15.15
Volume
2.92K
52 Week High
$42.86
52 Week Low
$13.14

PHVS Earnings

-$6.40
-$4.27
-$2.13
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Oct 29
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure